These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21068380)

  • 1. Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.
    Acehan D; Vaz F; Houtkooper RH; James J; Moore V; Tokunaga C; Kulik W; Wansapura J; Toth MJ; Strauss A; Khuchua Z
    J Biol Chem; 2011 Jan; 286(2):899-908. PubMed ID: 21068380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
    Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
    J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
    Kim J; Lee K; Fujioka H; Tandler B; Hoppel CL
    Mitochondrion; 2018 Nov; 43():53-62. PubMed ID: 30389594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
    Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafazzin Mutation Affecting Cardiolipin Leads to Increased Mitochondrial Superoxide Anions and Mitophagy Inhibition in Barth Syndrome.
    Petit PX; Ardilla-Osorio H; Penalvia L; Rainey NE
    Cells; 2020 Oct; 9(10):. PubMed ID: 33096711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
    Ikon N; Ryan RO
    Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.
    Ronvelia D; Greenwood J; Platt J; Hakim S; Zaragoza MV
    Mol Genet Metab; 2012 Nov; 107(3):428-32. PubMed ID: 23031367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
    Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
    PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
    Zegallai HM; Hatch GM
    Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Drosophila model of Barth syndrome.
    Xu Y; Condell M; Plesken H; Edelman-Novemsky I; Ma J; Ren M; Schlame M
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11584-8. PubMed ID: 16855048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes.
    He Q; Harris N; Ren J; Han X
    Oxid Med Cell Longev; 2014; 2014():654198. PubMed ID: 25247053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
    Chowdhury A; Aich A; Jain G; Wozny K; Lüchtenborg C; Hartmann M; Bernhard O; Balleiniger M; Alfar EA; Zieseniss A; Toischer K; Guan K; Rizzoli SO; Brügger B; Fischer A; Katschinski DM; Rehling P; Dudek J
    Cell Rep; 2018 Oct; 25(3):561-570.e6. PubMed ID: 30332638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Mitochondrial Ca
    Bertero E; Nickel A; Kohlhaas M; Hohl M; Sequeira V; Brune C; Schwemmlein J; Abeßer M; Schuh K; Kutschka I; Carlein C; Münker K; Atighetchi S; Müller A; Kazakov A; Kappl R; von der Malsburg K; van der Laan M; Schiuma AF; Böhm M; Laufs U; Hoth M; Rehling P; Kuhn M; Dudek J; von der Malsburg A; Prates Roma L; Maack C
    Circulation; 2021 Nov; 144(21):1694-1713. PubMed ID: 34648376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
    Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
    Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.